RE:CancerSeek - "Currently in Development"MrMaker1111 wrote: CancerSEEK is currently in development and is not yet available to patients. Information about enrolling in upcoming clinical trials will be provided in the future.
In a study published in Science in 2018, CancerSEEK performed with greater than 99% specificity and median 70% sensitivity among the cancer types evaluated. This approach enables doctors (and ultimately payers) to focus follow-up procedures on patients who truly have cancer and for whom the doctor can take meaningful treatment action. I believe Aristotle has a much higher median sensitivity